ADDING MULTIMEDIA CHMP Recommends Otsuka's Deltybaâ¢ (delamanid) for EU Approval for Treatment of Multidrug-Resistant Tuberculosis (MDR-TB) in Combination with Optimized Background Regimen (OBR)<4578.T>